{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:53:37Z","timestamp":1765230817170},"reference-count":20,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T00:00:00Z","timestamp":1066953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Fabry disease is a multisystem disorder associated with wide variability in clinical expression. Fabry disease is an X\u2010linked lysosomal storage disorder caused by a deficiency of \u03b1\u2010galactosidase\u00a0A. The enzyme defect leads to the systemic accumulation of glycosphingolipids with \u03b1\u2010galactosyl moieties consisting predominantly of globotriaosylceramide, galabiosylceramide and two additional glycosphingolipids.<\/jats:p><jats:p>Four hemizygotes patients with a family history of Fabry disease and deficiency of the enzyme \u03b1\u2010galactosidase\u00a0A were selected. Each patient received purified \u03b1\u2010galactosidase by intravenous infusion (0.2\u00a0mg\/kg). The infusion was administered every 2\u00a0weeks, for 40\u00a0min, for a total of 12\u00a0months. Outcome measures include neurological manifestations (acroparaesthesia, hypohidrosis, vasomotion), kidney function, cardiac manifestations, angiokeratomas, and corneal dystrophy.<\/jats:p><jats:p>\u03b1\u2010Galactosidase\u00a0A prepared from human fibroblast is safe and well tolerated. After 12\u00a0months of therapy the mean creatinine clearance increased, there was significant improvement in the acroparaesthesias and in the hypohidrosis. Physical stigmata, such as angiokeratomas in the skin, and characteristic benign corneal abnormalities remained stable.<\/jats:p><jats:p>Enzyme replacement therapy would therefore represent a significant advance in treatment of patients with Fabry disease. Enzyme replacement therapy is safe and likely to improve the prognosis of Fabry disease.<\/jats:p>","DOI":"10.1046\/j.1468-3083.2003.00831.x","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T10:15:18Z","timestamp":1066990518000},"page":"676-679","source":"Crossref","is-referenced-by-count":10,"title":["Fabry disease: enzyme replacement therapy"],"prefix":"10.1111","volume":"17","author":[{"given":"MR","family":"Bongiorno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196705252762101"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.167.3922.1268"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/rwgn.2001.0443"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1016\/S0021-9258(19)44007-6","article-title":"Characterization of a blood group B glycolipid accumulating in the pancreas of a patient with Fabry's disease","volume":"248","author":"Wherrett JR","year":"1973","journal-title":"J Biol Chem"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990611)84:5<420::AID-AJMG6>3.0.CO;2-Z"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.38.11.769"},{"key":"e_1_2_5_8_2","first-page":"1812","volume-title":"Fitzpatrick's Dermatology in General Medicine","author":"Desnick RJ","year":"1999"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01986897"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1898.tb16317.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000059897"},{"key":"e_1_2_5_12_2","first-page":"1055","article-title":"Outcome of end stage renal disease in patients with rare causes of renal failure. Inherited and metabolic disorders","volume":"73","author":"Nissenson AR","year":"1989","journal-title":"Q J Med"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012423924648"},{"key":"e_1_2_5_14_2","first-page":"469","article-title":"Cardiac variant of Fabry's disease mimicking hypertrophic cardiomyopathy","volume":"44","author":"Chimenti C","year":"1999","journal-title":"Cardiologia"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1746"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400105"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.3.9116979"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197307052890103"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.10.5326"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.365"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2743"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-3083.2003.00831.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-3083.2003.00831.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T19:59:23Z","timestamp":1695844763000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-3083.2003.00831.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,24]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1046\/j.1468-3083.2003.00831.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-3083.2003.00831.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,24]]}}}